Investigational vaccine protects cattle from respiratory syncytial virus

(NIH/National Institute of Allergy and Infectious Diseases) A novel vaccine developed by scientists at the National Institute of Allergy and Infectious Diseases, protected cattle from respiratory syncytial virus (RSV) infection, according to research published online in npj Vaccines on March 8. The version of RSV that naturally infects cattle is closely related to human RSV, so the results suggest that a similar human RSV vaccine construct may provide protection in humans, according to the study authors.
Source: EurekAlert! - Medicine and Health - Category: Global & Universal Source Type: news